| Thioredoxin—a fold for all reasons JL Martin Structure 3 (3), 245-250, 1995 | 1107 | 1995 |
| Human sulfotransferases and their role in chemical metabolism N Gamage, A Barnett, N Hempel, RG Duggleby, KF Windmill, JL Martin, ... Toxicological Sciences 90 (1), 5-22, 2006 | 841 | 2006 |
| SAM (dependent) I AM: the S-adenosylmethionine-dependent methyltransferase fold JL Martin, FM McMillan Current opinion in structural biology 12 (6), 783-793, 2002 | 701 | 2002 |
| Functional group contributions to drug-receptor interactions PR Andrews, DJ Craik, JL Martin Journal of medicinal chemistry 27 (12), 1648-1657, 1984 | 684 | 1984 |
| Crystal structure of the DsbA protein required for disulphide bond formation in vivo JL Martin, JCA Bardwell, J Kuriyan Nature 365 (6445), 464-468, 1993 | 497 | 1993 |
| Protein disulfide isomerase: the structure of oxidative folding CW Gruber, M Čemažar, B Heras, JL Martin, DJ Craik Trends in biochemical sciences 31 (8), 455-464, 2006 | 420 | 2006 |
| Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors D Leung, K Schroder, H White, NX Fang, MJ Stoermer, G Abbenante, ... Journal of Biological Chemistry 276 (49), 45762-45771, 2001 | 416 | 2001 |
| DSB proteins and bacterial pathogenicity B Heras, SR Shouldice, M Totsika, MJ Scanlon, MA Schembri, JL Martin Nature Reviews Microbiology 7 (3), 215-225, 2009 | 350 | 2009 |
| Post-crystallization treatments for improving diffraction quality of protein crystals B Heras, JL Martin Acta Crystallographica Section D: Biological Crystallography 61 (9), 1173-1180, 2005 | 309 | 2005 |
| Crystal structure of mammalian purple acid phosphatase LW Guddat, AS McAlpine, D Hume, S Hamilton, J de Jersey, JL Martin Structure 7 (7), 757-767, 1999 | 234 | 1999 |
| Crystal structures of reduced and oxidized DsbA: investigation of domain motion and thiolate stabilization LW Guddat, JCA Bardwell, JL Martin Structure 6 (6), 757-767, 1998 | 210 | 1998 |
| Targeting virulence not viability in the search for future antibacterials B Heras, MJ Scanlon, JL Martin British journal of clinical pharmacology 79 (2), 208-215, 2015 | 203 | 2015 |
| Structure of a Human Carcinogen-converting Enzyme, SULT1A1 structural and kinetic implications of substrate inhibition NU Gamage, RG Duggleby, AC Barnett, M Tresillian, CF Latham, ... Journal of Biological Chemistry 278 (9), 7655-7662, 2003 | 195 | 2003 |
| Structure of West Nile virus NS3 protease: ligand stabilization of the catalytic conformation G Robin, K Chappell, MJ Stoermer, SH Hu, PR Young, DP Fairlie, ... Journal of molecular biology 385 (5), 1568-1577, 2009 | 177 | 2009 |
| Glucose analogue inhibitors of glycogen phosphorylase: the design of potential drugs for diabetes JL Martin, K Veluraja, K Ross, LN Johnson, GWJ Fleet, NG Ramsden, ... Biochemistry 30 (42), 10101-10116, 1991 | 172 | 1991 |
| Structure of the Munc18c/Syntaxin4 N-peptide complex defines universal features of the N-peptide binding mode of Sec1/Munc18 proteins SH Hu, CF Latham, CL Gee, DE James, JL Martin Proceedings of the National Academy of Sciences 104 (21), 8773-8778, 2007 | 166 | 2007 |
| Crystal structure of Toll-like receptor adaptor MAL/TIRAP reveals the molecular basis for signal transduction and disease protection E Valkov, A Stamp, F DiMaio, D Baker, B Verstak, P Roversi, S Kellie, ... Proceedings of the National Academy of Sciences 108 (36), 14879-14884, 2011 | 163 | 2011 |
| Ten Simple Rules to Achieve Conference Speaker Gender Balance JL Martin PLOS Computational Biology 10 (11), e1003903, 2014 | 157 | 2014 |
| Crystal structure of human catecholamine sulfotransferase1 LM Bidwell, ME McManus, A Gaedigk, Y Kakuta, M Negishi, L Pedersen, ... Journal of molecular biology 293 (3), 521-530, 1999 | 152 | 1999 |
| Comparison of the binding of glucose and glucose 1-phosphate derivatives to T-state glycogen phosphorylase b JL Martin, LN Johnson, SG Withers Biochemistry 29 (48), 10745-10757, 1990 | 151 | 1990 |
